Page last updated: 2024-08-24

meglumine antimoniate and allopurinol

meglumine antimoniate has been researched along with allopurinol in 77 studies

Research

Studies (77)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (5.19)	18.7374
1990's	17 (22.08)	18.2507
2000's	17 (22.08)	29.6817
2010's	28 (36.36)	24.3611
2020's	11 (14.29)	2.80

Authors

Authors	Studies
Castillo, R; Hernández-Quero, J; Jiménez, E; Medrano, FJ; Pineda, JA; Reyes, MJ; Rivero, A; Sánchez-Quijano, A; Velez, ID; Viciana, P	1
Bouchouareb, D; Moulin, B; Ollier, J; Olmer, M; Purgus, R	1
Berman, JD; Herwaldt, BL; Neva, FA	1
Marr, JJ; Martinez, S	1
Casals, A; Clotet, B; Ribelles, N; Vallés, J	1
Chong, H	1
de la Cruz Amorós, E; Lambruschini Ferri, N; Rodríguez Miguélez, JM; Torres Simón, JM	1
Berman, JD; Chapman, WL; Hanson, WL; Jackson, JE; Klein, RS; Lovelace, JK; Waits, VB	1
Ahmad, E; Ghahramani, N; Javid, R; Malek Hosseini, SA; Nezakatgoo, N; Salahi, H	1
Aminjavaheri, M; Momeni, AZ	1
Alvar, J; González-Lahoz, JM; Laguna, F; López-Vélez, R; Montilla, P; Soriano, V	1
Altieri, S; di Martino, L; Ferrara, M; Gaeta, GB; Gradoni, L; Gramiccia, M; Pempinello, R; Pizzuti, R; Scotti, S	1
Cortes, E; de Otero, J; Gasser, I; Ocaña, I; Pahissa, A; Ribera, E	1
Agudelo, S; Berman, J; Grogl, M; Hendrickx, E; Modabber, F; Puerta, J; Velez, I	1
Camma, C; Cascio, A; Giordano, S; Gradoni, L; Gramiccia, M; Russo, R; Scalone, A; Scarlata, F; Titone, L	1
Amusategui, I; Sainz, A; Tesouro, MA	2
Alunda, JM; Cuquerella, M; de la Fuente, C; Fernández-Pérez, FJ; Gómez, MT; Méndez, S	1
Alsina, J; Bover, J; Gil-Vernet, S; Grinyó, JM; Hueso, M; Rufí, G; Serón, D	1
Greiner, M; Moritz, A; Steuber, S	1
Greiner, M; Moritz, A; Schirrmann, I; Steuber, S	1
Alberola, J; Arboix, M; Castillejo, S; Ferrer, L; Fisa, R; Gallego, M; Iniesta, L; Portús, M; Riera, C; Roura, X; Solano-Gallego, L; Valladares, JE	1
Bakirtaç, A; Kara, C; Kuyucu, N; Teziç, T	1
Aminjavaheri, M; Momeni, AZ; Reiszadae, MR	1
Alavi, A; Esfandiarpour, I	1
Bernal, LJ; Cerón, JJ; Martínez-Subiela, S	1
Diaz-Bertrana, MC; Durall, I; Franch, J; Lafuente, P; Munilla, A; Pastor, J; Torrent, E	1
Aceña, MC; Castillo, JA; Gascón, M; Gómez-Ochoa, P; Miana-Mena, FJ	1
Cortes, S; João, A; Pereira, MA; Santos-Gomes, GM	1
Costa, M; Ferrer, L; Martorell, S; Miranda, S; Ramis, A	1
Gravino, AE; Manna, L; Pavone, LM; Picillo, E; Reale, S; Vitale, F	1
Avallone, L; Ciaramella, P; Cortese, L; Di Loria, A; Lombardi, P; Mastellone, V; Pelagalli, A; Piantedosi, D	1
Dabiri, SH; Esfandiarpour, I	1
Compagnoni, F; Franceschi, A; Mancianti, F	1
Foglia Manzillo, V; Gradoni, L; Guglielmino, R; Oliva, G; Pagano, A; Restucci, B	1
Avallone, L; Cestaro, A; Ciaramella, P; Cortese, L; Di Loria, A; Lombardi, P; Pelagalli, A; Piantedosi, D	1
Bertazzolo, W; Dell'Orco, M; Paccioretti, F	1
Battikh, R; Belhadj, R; Berraies, N; Gargouri, S; Haloues, M; Harzallah, K; Hmida, J; Jemli, B; Manaa, J	1
Lamothe, J	1
Bianciardi, P; Cañavate, C; Cruz, I; Miró, G; Mortarino, M; Oliva, G; Vischer, C	1
Aflatoonian, MR; Dowlati, Y; Fekri, AR; Khamesipour, A; Mahboudi, F; Modabber, F; Nadim, A; Sharifi, I	1
Bardagí, M; Ferrer, L; Ravera, I; Roura, X; Torres, M; Zanna, G	1
Descalzo, MA; Fraile, C; Gálvez, R; Miró, G; Molina, R	1
Amato, ME; De Palo, P; Greco, B; Lubas, G; Paradies, P; Sasanelli, M	1
Amorim, IF; Azevedo, EG; da Silva, SM; Demicheli, C; Frézard, F; Gontijo, NF; Melo, MN; Michalick, MS; Ribeiro, RR; Tafuri, WL	1
Albuquerque, C; Campino, L; Cardoso, L; Dias, I; Machado, J; Pires, MA; Requicha, J; Sargo, T; Viegas, C	1
Dastgheib, L; Mirashe, Z; Naseri, M	1
Chatzis, MK; Kasabalis, D; Petanides, T; Saridomichelakis, MN; Steiner, JM; Suchodolski, JS; Xenoulis, PG	1
Campino, L; Henriques, S; Maia, C; Marques, M; Nunes, M; Rolão, N	1
Giordano, A; Ibba, F; Meazzi, S; Paltrinieri, S; Rossi, G	1
Cerrone, A; Corso, R; Galiero, G; Gravino, AE; Manna, L; Muzj, P	1
Alcántara, G; Checa, R; Chicharro, C; Cruz, I; de Quadros, LP; Gálvez, R; Hernández, L; Jiménez, MÁ; Mateo, M; Miró, G; Montoya, A	1
Alborch, L; Montserrat-Sangrà, S; Ordeix, L; Solano-Gallego, L	1
Cerón, JJ; Escribano, D; Kocaturk, M; Martínez-Subiela, S; Pardo-Marín, L; Torrecillas, A; Tvarijonaviciute, A; Yilmaz, Z	1
Cerón, JJ; Garcia-Martinez, JD; Martínez-Subiela, S; Pardo-Marín, L; Pastor, J; Segarra, S; Tvarijonaviciute, A	1
Burchmore, R; Ceron, JJ; Escribano, D; Horvatic, A; Kocaturk, M; Martinez-Subiela, S; Mrljak, V; Pardo-Marin, L; Yilmaz, Z	1
Baneth, G; Marí-Martorell, D; Martínez-Orellana, P; Montserrat-Sangrà, S; Ordeix, L; Solano-Gallego, L	1
Cordeiro-da-Silva, A; Dantas-Torres, F; Miró, G; Travi, BL	1
Azevedo, EG; Caliari, MMV; Castro, RS; de Amorim, IFG; Demicheli, C; Frezard, FJG; Michalick, MSM; Mosser, DM; Pereira, RA; Pinheiro, LJ; Pinto, AJW; Silva, SM; Tafuri, WL	1
Cantos-Barreda, A; Cerón, JJ; Escribano, D; Martínez-Subiela, S; Pardo-Marín, L; Segarra, S	1
Bernal, LJ; Cantos-Barreda, A; Cerón, JJ; Escribano, D; Martínez-Subiela, S; Tecles, F	1
Cerón, JJ; Checa, R; Daza González, MA; Fermín Rodríguez, M; Fragío Arnold, C; Martínez Subiela, S; Miró, G; Montoya, A; Portero Fuentes, M; Rupérez Noguer, C	1
Gómez, S; Palacio, MJF; Santarelli, G; Sebastián-Marcos, P	1
Daza González, MA; Fermín Rodríguez, M; Fragío Arnold, C; Miró, G; Rupérez Noguer, C	1
Apostolidis, K; Buono, A; Chatzis, MK; Kasabalis, D; Leontides, LS; Petanides, T; Polizopoulou, ZS; Saridomichelakis, MN; Steiner, JM; Suchodolski, JS; Xenoulis, PG	1
Arbeláez, N; Montoya, A; Moreno, J; Murillo, J; Robledo, SM; Vélez, A; Vélez, ID	1
Azinheira, S; Campino, L; Cristovão, JM; Maia, C; Parreira, R; Pereira, A; Valente, J	1
Apostolidis, K; Athanasiou, LV; Chatzis, MK; Ikonomopoulos, J; Kasabalis, D; Leontides, LS; Mataragka, A; Petanides, T; Saridomichelakis, MN; Xenoulis, PG	1
Alcover, MM; Basurco, A; Fani, C; Fernández, A; Fisa, R; Giner, J; Riera, C; Trotta, M; Verde, MT; Villanueva-Saz, S; Yzuel, A	1
Bitam, I; Davoust, B; Hamidat, HK; Lafri, I; Laidoudi, Y; Lounas, A; Mediannikov, O; Medkour, H; Mekroud, A; Varloud, M	1
Barbè, F; Ibba, F; Paltrinieri, S; Rossi, G	1
Chatzis, MK; Kasabalis, D; Saridomichelakis, MN; Steiner, JM; Suchodolski, JS; Xenoulis, PG	1
Aguiar-Soares, RDO; Andrade, HM; Brito, RCF; Cardoso, JMO; Frézard, F; Mathias, FAS; Ostolin, TLVDP; Ramos, GS; Reis, AB; Reis, LES; Roatt, BM; Vieira, JFP	1
Campos, MP; Figueiredo, FB; Gonçalves, AS; Gonçalves, G; Medeiros, LCS	1
Becattini, L; Ferrari, F; Masserdotti, C; Ottaiano, P; Tamborini, A; Tiozzo, AA	1
Darchini-Maragheh, E; Derakhshan, Z; Mashayekhi Goyonlo, V	1
Broere, F; de Jong, MK; Piek, CJ; Rappoldt, A	1

Reviews

3 review(s) available for meglumine antimoniate and allopurinol

Article	Year
Leishmaniasis: a rare cause of unexplained fever in a renal graft recipient. Nephron, 1992, Volume: 60, Issue:3 Topics: Adult; Allopurinol; Animals; Antimony; Antiprotozoal Agents; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Methylprednisolone; Muromonab-CD3; Organometallic Compounds	1992
Oriental sore. A look at trends in and approaches to the treatment of leishmaniasis. International journal of dermatology, 1986, Volume: 25, Issue:10 Topics: Allopurinol; Aminoquinolines; Antimony; Antimony Sodium Gluconate; Cryosurgery; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Levamisole; Liposomes; Meglumine; Meglumine Antimoniate; Metronidazole; Nifurtimox; Organometallic Compounds; Phenothiazines; Rifampin	1986
Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us. PLoS neglected tropical diseases, 2018, Volume: 12, Issue:1 Topics: Allopurinol; Animals; Antiprotozoal Agents; Disease Reservoirs; Dog Diseases; Dogs; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Molecular Diagnostic Techniques; Organometallic Compounds; Phosphorylcholine; Point-of-Care Systems; Serologic Tests	2018

Trials

18 trial(s) available for meglumine antimoniate and allopurinol

Article	Year
Allopurinol in the treatment of American cutaneous leishmaniasis. The New England journal of medicine, 1992, Aug-13, Volume: 327, Issue:7 Topics: Allopurinol; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1992
Allopurinol in the treatment of American cutaneous leishmaniasis. The New England journal of medicine, 1992, Mar-12, Volume: 326, Issue:11 Topics: Adolescent; Adult; Allopurinol; Antimony; Antiprotozoal Agents; Child, Preschool; Developing Countries; Drug Synergism; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1992
Treatment of recurrent cutaneous Leishmaniasis. International journal of dermatology, 1995, Volume: 34, Issue:2 Topics: Adolescent; Adult; Aged; Allopurinol; Antiprotozoal Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Treatment Outcome	1995
Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients. The American journal of medicine, 1996, Volume: 100, Issue:5 Topics: Adult; Aged; Allopurinol; Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Data Interpretation, Statistical; Female; Follow-Up Studies; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Multivariate Analysis; Organometallic Compounds; Recurrence; Retrospective Studies; Time Factors	1996
Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial. Annals of internal medicine, 1997, Feb-01, Volume: 126, Issue:3 Topics: Adult; Allopurinol; Antimetabolites; Antimony; Antiprotozoal Agents; Female; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Failure	1997
Clinical follow-up examination after treatment of canine leishmaniasis. The Tokai journal of experimental and clinical medicine, 1998, Volume: 23, Issue:6 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Follow-Up Studies; Leishmania infantum; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	1998
Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate. International journal of dermatology, 2002, Volume: 41, Issue:7 Topics: Adolescent; Adult; Allopurinol; Antimetabolites; Antiprotozoal Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome	2002
Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis. International journal of dermatology, 2002, Volume: 41, Issue:8 Topics: Administration, Oral; Adolescent; Allopurinol; Antiprotozoal Agents; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2002
Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment. American journal of veterinary research, 2003, Volume: 64, Issue:8 Topics: Acute-Phase Proteins; Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Female; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2003
Characterization of circulating lymphocyte subpopulations in canine leishmaniasis throughout treatment with antimonials and allopurinol. Veterinary parasitology, 2007, Mar-31, Volume: 144, Issue:3-4 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Leishmaniasis, Cutaneous; Lymphocyte Subsets; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Time Factors	2007
Effects of therapy on haemostasis in dogs infected with Leishmania infantum, Ehrlichia canis, or both combined. The Veterinary record, 2009, Apr-04, Volume: 164, Issue:14 Topics: Allopurinol; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Dog Diseases; Dogs; Doxycycline; Drug Combinations; Ehrlichia canis; Ehrlichiosis; Enzyme Inhibitors; Female; Hemostasis; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Platelet Aggregation; Treatment Outcome	2009
Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis. Veterinary dermatology, 2009, Volume: 20, Issue:5-6 Topics: Allopurinol; Animals; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine	2009
Monitoring the reverse to normal of clinico-pathological findings and the disease free interval time using four different treatment protocols for canine leishmaniosis in an endemic area. Research in veterinary science, 2012, Volume: 93, Issue:2 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Endemic Diseases; Female; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Time Factors	2012
Both combined oral azithromycin plus allopurinol and intramuscular Glucantime yield low efficacy in the treatment of Old World cutaneous leishmaniasis: a randomized controlled clinical trial. International journal of dermatology, 2012, Volume: 51, Issue:12 Topics: Administration, Oral; Adult; Allopurinol; Anti-Bacterial Agents; Antimetabolites; Antiprotozoal Agents; Azithromycin; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome	2012
Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol. Parasites & vectors, 2015, May-28, Volume: 8 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine; Retrospective Studies	2015
Evaluation of nephrotoxicity and ototoxicity of aminosidine (paromomycin)-allopurinol combination in dogs with leishmaniosis due to Leishmania infantum: A randomized, blinded, controlled study. Experimental parasitology, 2019, Volume: 206 Topics: Allopurinol; Animals; Cochlea; Creatinine; Dog Diseases; Dogs; Double-Blind Method; Drug Combinations; Evoked Potentials, Auditory, Brain Stem; Female; Hearing; Hearing Loss; Injections, Subcutaneous; Kidney; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Neurologic Examination; Paromomycin; Random Allocation; Vestibule, Labyrinth	2019
A randomized, blinded, controlled clinical trial comparing the efficacy of aminosidine (paromomycin)-allopurinol combination with the efficacy of meglumine antimoniate-allopurinol combination for the treatment of canine leishmaniosis due to Leishmania inf Experimental parasitology, 2020, Volume: 214 Topics: Allopurinol; Animals; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Injections, Subcutaneous; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Paromomycin; Trypanocidal Agents	2020
Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial. PLoS neglected tropical diseases, 2020, Volume: 14, Issue:12 Topics: Allopurinol; Animals; Antiprotozoal Agents; Artesunate; Dog Diseases; Dogs; Female; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Parasite Load; Parasitemia; Zoonoses	2020

Other Studies

56 other study(ies) available for meglumine antimoniate and allopurinol

Article	Year
Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain? AIDS (London, England), 1992, Volume: 6, Issue:12 Topics: Adult; AIDS-Related Opportunistic Infections; Allopurinol; Antiprotozoal Agents; CD4-Positive T-Lymphocytes; Female; HIV-1; Hospitals, University; Humans; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Retrospective Studies; Spain; Treatment Outcome	1992
[Visceral leishmaniasis with benign course in a patient infected with human immunodeficiency virus]. Medicina clinica, 1989, May-06, Volume: 92, Issue:17 Topics: Acquired Immunodeficiency Syndrome; Adult; Allopurinol; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prognosis	1989
[Glucantime and allopurinol in the treatment of persistent infantile visceral leishmaniasis]. Anales espanoles de pediatria, 1988, Volume: 29, Issue:1 Topics: Allopurinol; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunologic Tests; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol	1988
Activity of purine analogs against Leishmania donovani in vivo. Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:1 Topics: Administration, Oral; Allopurinol; Animals; Cricetinae; Formycins; Guanosine; Injections, Intramuscular; Inosine; Leishmania donovani; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Saimiri; Spleen	1987
A case report of Kala-Azar in a kidney transplant patient. Transplantation proceedings, 1995, Volume: 27, Issue:5 Topics: Adult; Allopurinol; Antiprotozoal Agents; Follow-Up Studies; Humans; Immunosuppression Therapy; Kidney Transplantation; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Splenectomy; Splenomegaly; Time Factors	1995
Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV. The Journal of infection, 1994, Volume: 28, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Allopurinol; Antiprotozoal Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Injections, Intramuscular; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pilot Projects	1994
The epidemiology and surveillance of visceral leishmaniasis in the Campania region of Italy. The value of zymodeme typing. Epidemiology and infection, 1993, Volume: 111, Issue:2 Topics: Adolescent; Adult; Allopurinol; Animals; Antiprotozoal Agents; Child; Child, Preschool; Disease Outbreaks; Female; Humans; Infant; Infant, Newborn; Isoenzymes; Italy; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Population Surveillance; Seasons; Skin Tests	1993
Epidemiologic surveillance of visceral leishmaniasis in Sicily, Italy. The American journal of tropical medicine and hygiene, 1997, Volume: 57, Issue:1 Topics: Adolescent; Adult; Age Distribution; Aged; Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Sex Distribution; Sicily	1997
Effects of antimonial therapy for canine leishmaniasis on antibody titer. Annals of the New York Academy of Sciences, 1998, Jun-29, Volume: 849 Topics: Allopurinol; Animals; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Injections, Intramuscular; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Time Factors	1998
Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis. Annals of the New York Academy of Sciences, 1998, Jun-29, Volume: 849 Topics: Allopurinol; Animals; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Follow-Up Studies; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Serum Albumin; Serum Globulins; Time Factors	1998
Value of Western blotting in the clinical follow-up of canine leishmaniasis. Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc, 1999, Volume: 11, Issue:2 Topics: Allopurinol; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Blotting, Western; Disease Progression; Dog Diseases; Dogs; Enzyme Inhibitors; Fluorescent Antibody Technique, Indirect; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sensitivity and Specificity; Treatment Outcome	1999
The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:12 Topics: Aged; Allopurinol; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Ketoconazole; Kidney Transplantation; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1999
PCR follow-up examination after treatment of canine leishmaniosis (CaL). The Tokai journal of experimental and clinical medicine, 1998, Volume: 23, Issue:6 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Follow-Up Studies; Humans; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Sensitivity and Specificity; Species Specificity	1998
Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment. Veterinary parasitology, 2001, Apr-19, Volume: 96, Issue:4 Topics: Allopurinol; Animals; Antibodies, Protozoan; Antibody Specificity; Antiprotozoal Agents; Dog Diseases; Dogs; Endemic Diseases; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Immunoglobulin G; Leishmania infantum; Leishmaniasis, Visceral; Longitudinal Studies; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Seroepidemiologic Studies; Spain	2001
Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate. The Pediatric infectious disease journal, 2001, Volume: 20, Issue:4 Topics: Acute Disease; Allopurinol; Antiprotozoal Agents; Child, Preschool; Humans; Ketoconazole; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis	2001
Management of leishmanial osteolytic lesions in a hypothyroid dog by partial tarsal arthrodesis. The Veterinary record, 2004, Oct-30, Volume: 155, Issue:18 Topics: Allopurinol; Animals; Antiprotozoal Agents; Arthrodesis; Dog Diseases; Dogs; Hindlimb; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tarsal Joints; Treatment Outcome	2004
Granulomatous lesion on a bitch's nipple caused by Leishmania infantum. The Veterinary record, 2005, Mar-19, Volume: 156, Issue:12 Topics: Allopurinol; Animals; Breast Diseases; Dog Diseases; Dogs; Female; Leishmania infantum; Leishmaniasis; Meglumine; Meglumine Antimoniate; Nipples; Organometallic Compounds	2005
Canine leishmaniasis chemotherapy: dog's clinical condition and risk of Leishmania transmission. Journal of veterinary medicine. A, Physiology, pathology, clinical medicine, 2006, Volume: 53, Issue:10 Topics: Allopurinol; Animals; Antiprotozoal Agents; Bone Marrow; Disease Transmission, Infectious; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Skin; Treatment Outcome; Trifluralin	2006
Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol. Veterinary journal (London, England : 1997), 2008, Volume: 177, Issue:2 Topics: Allopurinol; Animals; Antiprotozoal Agents; DNA, Protozoan; Dog Diseases; Dogs; Drug Therapy, Combination; Leishmania; Leishmaniasis; Lymph Nodes; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Skin	2008
The effects of prednisone on haemostasis in leishmaniotic dogs treated with meglumine antimoniate and allopurinol. Veterinary journal (London, England : 1997), 2008, Volume: 177, Issue:3 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Homeostasis; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Platelet Aggregation; Prednisone; Random Allocation; Risk Assessment	2008
Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study. International journal of dermatology, 2007, Volume: 46, Issue:8 Topics: Adolescent; Adult; Allopurinol; Animals; Antimetabolites; Antiprotozoal Agents; Child; Child, Preschool; Drug Therapy, Combination; Face; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Treatment Outcome	2007
A simple duplex-PCR protocol for routine diagnosis and follow up of canine leishmaniasis. Parassitologia, 2007, Volume: 49, Issue:1-2 Topics: Allopurinol; Animals; Antiprotozoal Agents; DNA, Kinetoplast; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Leishmania infantum; Leishmaniasis, Visceral; Lymph Nodes; Lymphadenitis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitemia; Phosphoric Monoester Hydrolases; Polymerase Chain Reaction; Predictive Value of Tests; Sensitivity and Specificity	2007
Extranodal gammadelta-T-cell lymphoma in a dog with leishmaniasis. Veterinary clinical pathology, 2008, Volume: 37, Issue:3 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmaniasis; Lymphoma, T-Cell; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2008
What is your diagnosis? Peritoneal effusion from a dog. Veterinary clinical pathology, 2009, Volume: 38, Issue:3 Topics: Allopurinol; Animals; Antiprotozoal Agents; Ascitic Fluid; Dog Diseases; Dogs; Female; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2009
Visceral leishmaniasis in a renal transplant recipient treated with allopurinol. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2010, Volume: 21, Issue:1 Topics: Allopurinol; Bone Marrow Examination; Humans; Immunosuppressive Agents; Kidney Transplantation; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Time Factors; Treatment Outcome; Trypanocidal Agents; Tunisia	2010
Some remarks about the LeishVet directions for the treatment of canine leishmaniasis. Veterinary parasitology, 2010, May-11, Volume: 169, Issue:3-4 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Resistance; Guidelines as Topic; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2010
Leishmaniasis recidivans among school children in Bam, South-east Iran, 1994-2006. International journal of dermatology, 2010, Volume: 49, Issue:5 Topics: Adolescent; Allopurinol; Child; Face; Female; Humans; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prevalence	2010
Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol. Veterinary journal (London, England : 1997), 2011, Volume: 188, Issue:3 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Follow-Up Studies; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Severity of Illness Index; Time Factors; Treatment Outcome	2011
Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments. Parasites & vectors, 2011, Apr-13, Volume: 4 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Europe; Female; Humans; Infectious Disease Transmission, Vertical; Leishmania infantum; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phlebotomus; Treatment Outcome	2011
Efficacy of combined therapy with liposome-encapsulated meglumine antimoniate and allopurinol in treatment of canine visceral leishmaniasis. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dogs; Female; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2012
Tongue nodules in canine leishmaniosis--a case report. Parasites & vectors, 2012, Jun-15, Volume: 5 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tongue; Tongue Diseases	2012
Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate. Veterinary parasitology, 2013, Oct-18, Volume: 197, Issue:1-2 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Hypothyroidism; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Thyrotropin; Thyroxine	2013
In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs. Experimental parasitology, 2013, Volume: 135, Issue:1 Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Deoxycholic Acid; Disease Reservoirs; Dog Diseases; Dogs; Drug Combinations; Humans; Immunocompetence; Immunocompromised Host; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphorylcholine	2013
Paraoxonase activity as a tool for clinical monitoring of dogs treated for canine leishmaniasis. Veterinary journal (London, England : 1997), 2014, Volume: 199, Issue:1 Topics: Allopurinol; Animals; Antiprotozoal Agents; Aryldialkylphosphatase; Biomarkers; Case-Control Studies; Dog Diseases; Dogs; Drug Therapy, Combination; Enzyme Activation; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2014
LEISHMANIA INFANTUM INFECTION IN BENNETT'S WALLABIES (MACROPUS RUFOGRISEUS RUFOGRISEUS) IN A SPANISH WILDLIFE PARK. Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2016, Volume: 47, Issue:2 Topics: Allopurinol; Animals; Animals, Zoo; Female; Insect Vectors; Leishmania infantum; Leishmaniasis, Visceral; Macropodidae; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Psychodidae; Spain	2016
TLR-2 and TLR-4 transcriptions in unstimulated blood from dogs with leishmaniosis due to Leishmania infantum at the time of diagnosis and during follow-up treatment. Veterinary parasitology, 2016, Sep-15, Volume: 228 Topics: Allopurinol; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Follow-Up Studies; Leishmania infantum; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasite Load; Parasitemia; Toll-Like Receptor 2; Toll-Like Receptor 4; Up-Regulation	2016
Serum apolipoprotein-A1 as a possible biomarker for monitoring treatment of canine leishmaniosis. Comparative immunology, microbiology and infectious diseases, 2016, Volume: 49 Topics: Allopurinol; Animals; Antiprotozoal Agents; Apolipoprotein A-I; Biomarkers; Dogs; Electrophoresis, Gel, Two-Dimensional; Leishmaniasis; Mass Spectrometry; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Proteome	2016
Evaluation of various biomarkers for kidney monitoring during canine leishmaniosis treatment. BMC veterinary research, 2017, Jan-23, Volume: 13, Issue:1 Topics: Allopurinol; Animals; Antimetabolites; Antiprotozoal Agents; Biomarkers; Dog Diseases; Dogs; Drug Therapy, Combination; Kidney Diseases; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Proteinuria	2017
Identification of novel biomarkers for treatment monitoring in canine leishmaniosis by high-resolution quantitative proteomic analysis. Veterinary immunology and immunopathology, 2017, Volume: 191 Topics: Acute-Phase Proteins; Allopurinol; Animals; Antiprotozoal Agents; Biomarkers; Dog Diseases; Dogs; Female; Ferritins; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Proteomics; Serum Globulins	2017
Leishmania infantum-specific IFN-γ production in stimulated blood from dogs with clinical leishmaniosis at diagnosis and during treatment. Veterinary parasitology, 2017, Dec-15, Volume: 248 Topics: Allopurinol; Animals; Dog Diseases; Dogs; Female; Interferon-gamma; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Trypanocidal Agents	2017
Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol. Veterinary parasitology, 2018, Jan-30, Volume: 250 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Gene Expression Regulation; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Liver; Liver Cirrhosis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Random Allocation; Transforming Growth Factor beta; Vimentin	2018
Changes in serum anti-Leishmania antibody concentrations measured by time-resolved immunofluorometric assays in dogs with leishmaniosis after treatment. Veterinary immunology and immunopathology, 2018, Volume: 198 Topics: Allopurinol; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Enzyme-Linked Immunosorbent Assay; Fluoroimmunoassay; Immunoglobulin A; Immunoglobulin G; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2018
Changes in the concentration of anti-Leishmania antibodies in saliva of dogs with clinical leishmaniosis after short-term treatment. Veterinary parasitology, 2018, Apr-30, Volume: 254 Topics: Allopurinol; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Saliva	2018
Effect of two treatments on changes in serum acute phase protein concentrations in dogs with clinical leishmaniosis. Veterinary journal (London, England : 1997), 2019, Volume: 245 Topics: Acute-Phase Proteins; Allopurinol; Animals; Antiprotozoal Agents; Aryldialkylphosphatase; Dog Diseases; Dogs; Leishmania infantum; Leishmaniasis, Visceral; Meglumine Antimoniate; Phosphorylcholine	2019
Canine leishmaniasis associated with pericardial effusion in a 4-year-old dog. Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology, 2019, Volume: 23 Topics: Allopurinol; Animals; Antiprotozoal Agents; Cardiac Tamponade; Dog Diseases; Dogs; Echocardiography; Leishmania; Leishmaniasis; Meglumine Antimoniate; Pericardial Effusion; Pericardial Fluid	2019
Short term impacts of meglumine antimoniate treatment on kidney function in dogs with clinical leishmaniosis. Research in veterinary science, 2019, Volume: 126 Topics: Allopurinol; Animals; Antiprotozoal Agents; Biomarkers; Creatinine; Dog Diseases; Dogs; Female; Glomerular Filtration Rate; Kidney Diseases; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine Antimoniate	2019
First Report of an Urban Case of Canine Visceral Leishmaniasis in the Municipality of Cali, Colombia. The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:2 Topics: Allopurinol; Animals; Antimetabolites; Antiprotozoal Agents; Base Sequence; Cities; Colombia; DNA, Protozoan; Dog Diseases; Dogs; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine Antimoniate	2020
An Unusual Case of Feline Leishmaniosis With Involvement of the Mammary Glands. Topics in companion animal medicine, 2019, Volume: 37 Topics: Allopurinol; Animals; Antiprotozoal Agents; Cat Diseases; Cats; Female; Leishmania donovani; Leishmaniasis; Leukemia Virus, Feline; Leukemia, Feline; Mammary Glands, Animal; Meglumine Antimoniate; Portugal; Uveitis	2019
Treatment and follow-up of a domestic ferret (Mustela putorius furo) with clinical leishmaniosis caused by Leishmania infantum. Veterinary parasitology, regional studies and reports, 2020, Volume: 21 Topics: Allopurinol; Animals; Antiparasitic Agents; Drug Therapy, Combination; Female; Ferrets; Leishmania infantum; Leishmaniasis, Visceral; Meglumine Antimoniate; Trypanocidal Agents	2020
Influence of domperidone supplementation on short-term changes in C-reactive protein and paraoxonase-1 in dogs with leishmaniasis undergoing meglumine antimoniate and allopurinol therapy. Veterinary clinical pathology, 2020, Volume: 49, Issue:4 Topics: Allopurinol; Animals; Aryldialkylphosphatase; C-Reactive Protein; Dietary Supplements; Dog Diseases; Dogs; Domperidone; Leishmaniasis; Meglumine Antimoniate	2020
Serum cobalamin concentrations in dogs with leishmaniosis before and during treatment. Comparative immunology, microbiology and infectious diseases, 2021, Volume: 78 Topics: Allopurinol; Animals; Dog Diseases; Dogs; Leishmania infantum; Leishmaniasis; Leishmaniasis, Visceral; Meglumine Antimoniate; Vitamin B 12	2021
Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis. Molecular immunology, 2022, Volume: 141 Topics: Allopurinol; Animals; Antibodies, Monoclonal; CD4-Positive T-Lymphocytes; Dog Diseases; Dogs; Immunologic Factors; Immunotherapy; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Meglumine Antimoniate; Organometallic Compounds; Polyethylene Glycols; Receptors, Interleukin-10	2022
Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol. Parasites & vectors, 2021, Dec-09, Volume: 14, Issue:1 Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Resistance; Female; Leishmania infantum; Leishmaniasis, Visceral; Meglumine Antimoniate; Phosphorylcholine	2021
Long-term follow-up of a case of feline leishmaniosis treated with a combination of allopurinol and meglumine antimoniate. The Canadian veterinary journal = La revue veterinaire canadienne, 2023, Volume: 64, Issue:3 Topics: Acute Kidney Injury; Allopurinol; Animals; Cat Diseases; Cats; Follow-Up Studies; Leishmaniasis; Meglumine Antimoniate	2023
Treatment of Cutaneous Leishmaniasis with Allopurinol Plus Itraconazole in Iran. The American journal of tropical medicine and hygiene, 2023, 06-07, Volume: 108, Issue:6 Topics: Allopurinol; Antiprotozoal Agents; Humans; Iran; Itraconazole; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2023
Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy. Parasites & vectors, 2023, May-15, Volume: 16, Issue:1 Topics: Allopurinol; Animals; Creatinine; Dog Diseases; Dogs; Humans; Leishmania infantum; Leishmaniasis; Leishmaniasis, Visceral; Meglumine Antimoniate; Prognosis; Recurrence; Urea	2023